The 340B drug discount program, part of the Public Health Service Act of 1992, lowers drug costs and increases revenues for safety-net healthcare providers by allowing them to pay heavily discounted prices for prescription drugs, but get reimbursed at full cost.
Researchers analyzed data from approximately 50% of all registered medical cannabis users in Minnesota between June 2016 and November 2019 to characterize the extent of their exposure to cannabis products.
A $6.5 million contract will allow the Chemical Synthesis Facility (CSF) to continue its work on contraceptive development, especially for male contraceptives.